Patents by Inventor Jesper Neergaard
Jesper Neergaard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12245627Abstract: An oral pouched product is disclosed, the oral pouched product includes a saliva permeable pouch, a non-tobacco pouch composition, the pouch composition includes heat-treated fibers, nicotine in an amount of 0.1-5.0% by weight of the pouch compositions, water in an amount 15-65% by weight of the pouch composition, at least one sugar alcohol, and less than 0.5% preservative by weight of the pouch composition. Also, a method for manufacturing an oral pouched product is disclosed.Type: GrantFiled: June 23, 2022Date of Patent: March 11, 2025Assignee: PHILIP MORRIS PRODUCTS S.A.Inventors: My Ly Lao Stahl, Heidi Ziegler Bruun, Bruno Provstgaard Nielsen, Jesper Neergaard, Bine Hare Jakobsen
-
Patent number: 11930838Abstract: An oral pouched product is disclosed, the pouched product comprising a saliva permeable pouch and a pouch composition, the pouch composition comprising a powdered composition, water, and a liquid flavor composition, wherein the liquid flavor composition is added to the powdered composition after the water. A further oral pouched product and a method of manufacturing an oral pouched product is disclosed.Type: GrantFiled: June 5, 2020Date of Patent: March 19, 2024Assignee: PHILIP MORRIS PRODUCTS S.A.Inventors: My Ly Lao Stahl, Heidi Ziegler Bruun, Bruno Provstgaard Nielsen, Jesper Neergaard, Bine Hare Jakobsen
-
Patent number: 11805802Abstract: A nicotine pouch composition is disclosed, the pouch composition includes at least one sugar alcohol, at least one water-insoluble fiber, water in an amount of 8-65% by weight of the composition, and nicotine. Also, an oral pouched nicotine product and a method for manufacturing an oral pouched product is disclosed.Type: GrantFiled: June 5, 2020Date of Patent: November 7, 2023Assignee: PHILIP MORRIS PRODUCTS S.A.Inventors: My Ly Lao Stahl, Heidi Ziegler Bruun, Bruno Provstgaard Nielsen, Jesper Neergaard, Bine Hare Jakobsen
-
Patent number: 11730757Abstract: The invention relates to a solid pharmaceutical tablet for oral delivery, the tablet comprising calcium carbonate in an amount of more than 30% by weight of the tablet and organic water-insoluble components in an amount of more than 20% by weight of the tablet, wherein the tablet is designed to be masticated into a coherent residual containing the organic water-insoluble components, and wherein the tablet is adapted to release more than 80% of the calcium carbonate within 5 minutes of mastication.Type: GrantFiled: March 21, 2019Date of Patent: August 22, 2023Assignee: Fertin Pharma A/SInventor: Jesper Neergaard
-
Patent number: 11723918Abstract: The invention relates to a solid pharmaceutical tablet for oral delivery, the tablet comprising calcium carbonate in an amount of more than 30% by weight of the tablet and organic water-insoluble components in an amount of more than 20% by weight of the tablet, wherein the tablet is designed to be masticated into a coherent residual containing the organic water-insoluble components, and wherein the tablet is adapted to release more than 80% of the calcium carbonate within 5 minutes of mastication.Type: GrantFiled: March 19, 2021Date of Patent: August 15, 2023Assignee: FERTIN PHARMA A/SInventor: Jesper Neergaard
-
Publication number: 20220322727Abstract: An oral pouched product is disclosed, the oral pouched product includes a saliva permeable pouch, a non-tobacco pouch composition, the pouch composition includes heat-treated fibers, nicotine in an amount of 0.1-5.0% by weight of the pouch compositions, water in an amount 15-65% by weight of the pouch composition, at least one sugar alcohol, and less than 0.5% preservative by weight of the pouch composition. Also, a method for manufacturing an oral pouched product is disclosed.Type: ApplicationFiled: June 23, 2022Publication date: October 13, 2022Inventors: My Ly Lao Stahl, Heidi Ziegler Bruun, Bruno Provstgaard Nielsen, Jesper Neergaard, Bine Hare Jakobsen
-
Patent number: 11399562Abstract: An oral pouched product is disclosed, the oral pouched product includes a saliva permeable pouch, a pouch composition, the pouch composition includes heat-treated fibers, nicotine, water in an amount of less than 65% by weight of the pouch composition, and at least one sugar alcohol. Also, a method for manufacturing an oral pouched product is disclosed.Type: GrantFiled: June 5, 2020Date of Patent: August 2, 2022Assignee: NCP NextGen A/SInventors: My Ly Lao Stahl, Heidi Ziegler Bruun, Bruno Provstgaard Nielsen, Jesper Neergaard, Bine Hare Jakobsen
-
Patent number: 11311623Abstract: The present invention relates to a nicotine delivery product comprising, or even consisting essentially of, a population of nicotine-loaded cation exchange resin particles, said population comprises at least 50% (w/w) particles having a size in the range of 90-300 micron which provides an improved nicotine stability to oral dosage forms comprising the nicotine delivery product. The invention furthermore relates to methods of producing the nicotine delivery product and the oral dosage forms and to the use of the nicotine delivery product.Type: GrantFiled: April 21, 2016Date of Patent: April 26, 2022Assignee: Fertin Pharma A/SInventors: Jesper Thorsen, Bjarne Vestbö, Birgitte Kringelum Breindal, Jesper Neergaard
-
Publication number: 20220087929Abstract: An oral pouched product is disclosed, the oral pouched product includes a saliva permeable pouch, a pouch composition, the pouch composition includes heat-treated fibers, nicotine, water in an amount of less than 65% by weight of the pouch composition, and at least one sugar alcohol. Also, a method for manufacturing an oral pouched product is disclosed.Type: ApplicationFiled: June 5, 2020Publication date: March 24, 2022Applicant: NCP NextGen A/SInventors: My Ly Lao Stahl, Heidi Ziegler Bruun, Bruno Provstgaard Nielsen, Jesper Neergaard, Bine Hare Jakobsen
-
Publication number: 20220039455Abstract: An oral pouched product is disclosed, the pouched product comprising a saliva permeable pouch and a pouch composition, the pouch composition comprising a powdered composition, water, and a liquid flavor composition, wherein the liquid flavor composition is added to the powdered composition after the water. A further oral pouched product and a method of manufacturing an oral pouched product is disclosed.Type: ApplicationFiled: June 5, 2020Publication date: February 10, 2022Applicant: NCP NextGen A/SInventors: My Ly Lao Stahl, Heidi Ziegler Bruun, Bruno Provstgaard Nielsen, Jesper Neergaard, Bine Hare Jakobsen
-
Publication number: 20210307375Abstract: A nicotine pouch composition is disclosed, the pouch composition includes at least one sugar alcohol, at least one water-insoluble fiber, water in an amount of 8-65% by weight of the composition, and nicotine. Also, an oral pouched nicotine product and a method for manufacturing an oral pouched product is disclosed.Type: ApplicationFiled: June 5, 2020Publication date: October 7, 2021Inventors: My Ly Lao STAHL, Heidi Ziegler BRUUN, Bruno Provstgaard NIELSEN, Jesper NEERGAARD, Bine Hare JAKOBSEN
-
Publication number: 20210205355Abstract: The invention relates to a solid pharmaceutical tablet for oral delivery, the tablet comprising calcium carbonate in an amount of more than 30% by weight of the tablet and organic water-insoluble components in an amount of more than 20% by weight of the tablet, wherein the tablet is designed to be masticated into a coherent residual containing the organic water-insoluble components, and wherein the tablet is adapted to release more than 80% of the calcium carbonate within 5 minutes of mastication.Type: ApplicationFiled: March 19, 2021Publication date: July 8, 2021Inventor: Jesper NEERGAARD
-
Patent number: 10980831Abstract: The invention relates to a solid pharmaceutical tablet for oral delivery, the tablet comprising calcium carbonate in an amount of more than 30% by weight of the tablet and organic water-insoluble components in an amount of more than 20% by weight of the tablet, wherein the tablet is designed to be masticated into a coherent residual containing the organic water-insoluble components, and wherein the tablet is adapted to release more than 80% of the calcium carbonate within 5 minutes of mastication.Type: GrantFiled: March 23, 2018Date of Patent: April 20, 2021Assignee: FERTIN PHARMA A/SInventor: Jesper Neergaard
-
Patent number: 10945949Abstract: A medical chewing gum including gum base polymers and one or more cannabinoids as an active pharmaceutical ingredient, the gum base polymers including polyvinyl acetate and vinyl laurate-vinyl acetate copolymer in an amount of more than 90% by weight of the gum base polymers, wherein the gum base polymers include 20-95% by weight of polyvinyl acetate and 5-80% by weight of vinyl laurate-vinyl acetate copolymer.Type: GrantFiled: October 7, 2015Date of Patent: March 16, 2021Inventors: Jesper Neergaard, Anayo Ogbonna
-
Publication number: 20210023128Abstract: The invention relates to a solid pharmaceutical tablet for oral delivery, the tablet comprising calcium carbonate in an amount of more than 30% by weight of the tablet and organic water-insoluble components in an amount of more than 20% by weight of the tablet, wherein the tablet is designed to be masticated into a coherent residual containing the organic water-insoluble components, and wherein the tablet is adapted to release more than 80% of the calcium carbonate within 5 minutes of mastication.Type: ApplicationFiled: March 21, 2019Publication date: January 28, 2021Applicant: Fertin Pharma A/SInventor: Jesper Neergaard
-
Patent number: 10485247Abstract: A nicotine chewing gum is disclosed, the nicotine chewing gum having gum base polymers, nicotine, and microcrystalline cellulose as a carrier for the nicotine, the gum base polymers include polyvinyl acetate and vinyl laurate-vinyl acetate copolymer in an amount of more than 90% by weight of the gum base polymers, and the gum base polymers include 20-95% by weight of polyvinyl acetate and 5-80% by weight of vinyl laurate-vinyl acetate copolymer. Also, a method for producing a nicotine chewing gum is disclosed.Type: GrantFiled: October 7, 2015Date of Patent: November 26, 2019Assignee: Fertin Pharma A/SInventor: Jesper Neergaard
-
Patent number: 10426726Abstract: The invention relates to a medical chewing gum comprising gum base polymers and an active pharmaceutical ingredient, the gum base polymers comprising polyvinyl acetate and vinyl laurate-vinyl acetate copolymer in an amount of more than 90% by weight, wherein the gum base polymers include 20-95% by weight of polyvinyl acetate and -80% by weight of vinyl laurate-vinyl acetate copolymer, and wherein the chewing gum contains no polyterpene resins and no resins based on gum rosin, wood rosin or tall oil resin.Type: GrantFiled: April 8, 2015Date of Patent: October 1, 2019Assignee: FERTIN PHARMA A/SInventor: Jesper Neergaard
-
Publication number: 20190290684Abstract: The invention relates to a solid pharmaceutical tablet for oral delivery, the tablet comprising calcium carbonate in an amount of more than 30% by weight of the tablet and organic water-insoluble components in an amount of more than 20% by weight of the tablet, wherein the tablet is designed to be masticated into a coherent residual containing the organic water-insoluble components, and wherein the tablet is adapted to release more than 80% of the calcium carbonate within 5 minutes of mastication.Type: ApplicationFiled: March 23, 2018Publication date: September 26, 2019Inventor: JESPER NEERGAARD
-
Publication number: 20190134207Abstract: The present invention relates to a nicotine delivery product comprising, or even consisting essentially of, a population of nicotine-loaded cation exchange resin particles, said population comprises at least 50% (w/w) particles having a size in the range of 90-300 micron which provides an improved nicotine stability to oral dosage forms comprising the nicotine delivery product. The invention furthermore relates to methods of producing the nicotine delivery product and the oral dosage forms and to the use of the nicotine delivery product.Type: ApplicationFiled: April 21, 2016Publication date: May 9, 2019Applicant: Fertin Pharma A/SInventors: Jesper Thorsen, Bjarne Vestbö, Birgitte Kringelum Breindal, Jesper Neergaard
-
Publication number: 20190060229Abstract: A medical chewing gum including gum base polymers and one or more cannabinoids as an active pharmaceutical ingredient, the gum base polymers including polyvinyl acetate and vinyl laurate-vinyl acetate copolymer in an amount of more than 90% by weight of the gum base polymers, wherein the gum base polymers include 20-95% by weight of polyvinyl acetate and 5-80% by weight of vinyl laurate-vinyl acetate copolymer.Type: ApplicationFiled: October 7, 2015Publication date: February 28, 2019Inventors: Jesper Neergaard, Anayo Ogbonna